MeiraGTx Holdings plc Profile Avatar - Palmy Investing

MeiraGTx Holdings plc

MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following…

Biotechnology
US, New York [HQ]
Financials

Analysts

Reported
Past Estimate Consensus
Future Estimate Consensus
EPS Revenue EBITDA EBIT SGA
FY EPS Revenue [mil.] Profit [mil.] EBITDA [mil.] EBIT [mil.] Expenses · SGA [mil.]
E E E E E E
2019 -4.3700 -2.027 0 6 -82 -114 -78 -6 -80 -6 44 16
2020 -1.5800 -1.581 13 17 -52 -89 -51 -17 -58 -17 46 44
2021 -1.4300 -2.060 15 22 -53 -116 -53 -22 -62 -22 44 58
2022 -1.6300 -2.687 37 32 -71 -151 -71 -32 -81 -32 43 90
2023 -3.1600 -1.682 15 40 -142 -84 -115 -40 -125 -40 46 111
2024 -1.4900 -1.822 14 31 -84 -102 -57 -31 -137 -31 47 87
2025 - 0.702 - 205 - 88 - -205 - -205 - 566
2026 - 2.F7X/td> - 2.F7X/td> - 2.F7X/td> - 2.F71/td> - 2.F71 - 2.F71
2027 - 1.F8X/td> - 1.F8X/td> - 1.F8X/td> - 1.F81/td> - 1.F81 - 1.F81
2028 - 0.F9X/td> - 0.F9X/td> - 0.F9X/td> - 0.F91/td> - 0.F91 - 0.F91
End of MGTX's Analysis
CIK: 1735438 CUSIP: G59665102 ISIN: KYG596651029 LEI: - UEI: -
Secondary Listings
MGTX has no secondary listings inside our databases.